One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

Ayalew Tefferi(Mayo Clinic in Arizona), Terra L. Lasho(University of Minnesota Rochester), Thitina Jimma(University of Minnesota Rochester), Christy M. Finke(University of Minnesota Rochester), Naseema Gangat(University of Minnesota Rochester), Rakhee Vaidya(Mayo Clinic in Arizona), Kebede H. Begna(Mayo Clinic in Arizona), Aref Al‐Kali(University of Minnesota Rochester), Rhett P. Ketterling(University of Minnesota Rochester), Curtis A. Hanson(University of Minnesota Rochester), Animesh Pardanani(University of Minnesota Rochester)
Mayo Clinic Proceedings
January 1, 2012
10.1016/j.mayocp.2011.11.001
Cited by 248Open Access
Full Text

Abstract

Related Papers

International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al.|Blood|1997|4.5k
Editorial: Some Speculations on the Myeloproliferative Syndromes
William Dameshek|Blood|1951|1.1k
Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms
Ayalew Tefferi, J. W. Vardiman|Leukemia|2007|993
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi et al.|Blood|2009|965
Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.
Michelle A. Kelliher, J McLaughlin, Owen N. Witte et al.|Proceedings of the National Academy of Sciences|1990|521